# Primary Venture Partners Portfolio Deep Dive

**Research Date:** February 18, 2026  
**Researcher:** Subagent research-primary-portfolio

## Executive Summary

Primary Venture Partners is a seed-stage VC firm based in NYC with ~$1.65B AUM. They follow a "low-volume, high-conviction" approach and have an outsized Portfolio Impact team. Their track record includes 1/3 of Fund I companies becoming unicorns, with portfolio companies 2x more likely to raise Series A and 19x more likely to reach $1B+ valuation.

---

## Last 10 Investments (Most Recent First)

### 1. **The Biological Computing Company (TBC)**
- **Investment:** $25M Seed (Feb 2026, Primary led)
- **What they do:** Building organic computing platform using living neurons to augment AI. Connects real neural networks with modern AI via electrodes, demonstrating 23x efficiency improvement in video models
- **Stage:** Seed
- **AI/Agent Angle:** ðŸ”¥ **Revolutionary compute infrastructure** - First true commercialization of biological computing. Uses living neurons (not neuromorphic chips) to make frontier models more stable, scalable, and efficient. Also extracts principles from living neural networks to inform novel AI architectures
- **Notable:** Founders are neurosurgeons from UMD/Penn. Brain operates at 1M times more energy efficiency than silicon (20W vs 120K watts for equivalent compute)

### 2. **Valerie Health**
- **Investment:** Series A (Dec 16, 2025)
- **What they do:** AI-enabled platform automating healthcare tasks for independent provider groups, modernizing patient experiences
- **Stage:** Series A
- **AI/Agent Angle:** ðŸ¤– **Healthcare automation** - AI-powered platform to automate clinical and administrative workflows
- **Notable:** Founded 2024 by Peter Shalek and Nitin Joshi. Co-investors: General Catalyst, Redpoint Ventures, .406 Ventures

### 3. **Bobyard**
- **Investment:** $35M Series A (Dec 10, 2025, participated)
- **What they do:** Automates construction estimating with trade-specific computer vision models, helping contractors bid faster
- **Stage:** Series A (led by 8VC)
- **AI/Agent Angle:** ðŸŽ¯ **Vertical AI for construction** - Computer vision models specialized for construction trades. Turns hours of manual work into minutes
- **Notable:** Founded 2023. Focused on landscaping/construction takeoff process. Co-investors: Pear VC, Tishman Speyer, RXR

### 4. **1mind**
- **Investment:** $40M total funding (Nov 2025, Primary participated)
- **What they do:** AI-led GTM platform deploying "Superhumans" - AI digital teammates with face, voice, and GTM brain for 24/7 buyer engagement
- **Stage:** Series A
- **AI/Agent Angle:** ðŸš€ **Pure AI agent play** - Replaces full-time sales employees with highly skilled, persuasive AI agents. Engage across websites, products, live video calls, and deal rooms
- **Notable:** Emotionally intelligent AI that "augments and ultimately replaces full-time employees" - most explicit agent-as-replacement positioning

### 5. **Tabs**
- **Investment:** Series B (Sep 2025, $55M led by Lightspeed, Primary participated)
- **What they do:** AI-native revenue platform for modern finance teams, bringing AI agents to the CFO's office
- **Stage:** Series B
- **AI/Agent Angle:** ðŸ¤– **Finance AI agents** - First AI-native revenue platform purpose-built for finance teams. Automates billing, revenue recognition, and financial operations
- **Notable:** Earlier seed investment by Primary. Co-investors: General Catalyst, Lightspeed

### 6. **Inspiren**
- **Investment:** $35M Series A (Mar 2025, led by Avenir, Primary participated)
- **What they do:** AI-powered senior living technology - integrates care planning, resident safety, staff efficiency into one system
- **Stage:** Series A
- **AI/Agent Angle:** ðŸ¥ **AI for senior care** - AI ecosystem that reduces falls by 68%, increases occupancy 22%. Monitors patient care, tracks interactions, improves clinical workflows
- **Notable:** Also received follow-on investment. Co-investors: Story Ventures, Third Prime, Studio VC

### 7. **Maybern**
- **Investment:** $50M Series B (2024/2025, Primary participated; earlier $14M in May 2024 at $80M valuation)
- **What they do:** Fund management platform for private equity, replacing spreadsheets running billion-dollar portfolios
- **Stage:** Series B
- **AI/Agent Angle:** ðŸ’¼ **Fintech automation** - Automates complex capital calls, distributions, waterfalls, fee calculations. Reduces reliance on messy Excel sheets
- **Notable:** Targets private equity accounting/fund administration mess

### 8. **Etched**
- **Investment:** $500M Series B (Jan 2026) + $120M Series A (Jun 2024, Primary led)
- **What they do:** AI chip startup building ASICs specialized for transformer inference to challenge Nvidia
- **Stage:** Series B
- **AI/Agent Angle:** ðŸ’» **AI infrastructure/compute** - Hardware optimized specifically for AI inference. Betting that most AI workloads will run on transformers long-term
- **Notable:** Co-led Series A with Positive Sum Ventures. Nvidia itself is an investor (!)
- **Founders:** College dropouts. CEO Gavin Uberti started with compiler optimizations

### 9. **Dandelion Health**
- **Investment:** $15.9M total (timing unclear, seed/early)
- **What they do:** Product development platform for clinical AI - partners with health systems to make de-identified patient data available to AI developers
- **Stage:** Seed/Early
- **AI/Agent Angle:** ðŸ§¬ **AI data infrastructure for healthcare** - Data marketplace enabling AI developers to access clinical data ethically and safely
- **Notable:** Co-investors: Convergent Ventures, Floating Point, Moxxie Ventures, Phoenix Venture Partners

### 10. **Alloy**
- **Investment:** Early seed investor (timing unclear, early 2010s)
- **What they do:** Identity and risk management platform for financial services - end-to-end identity verification, fraud prevention, monitoring, credit underwriting
- **Stage:** Growth (now valued at $1.4B+)
- **AI/Agent Angle:** ðŸ›¡ï¸ **Risk intelligence/decision automation** - Brings together risk intelligence sources to optimize growth while minimizing fraud. Real-time risk monitoring and automated decisioning
- **Notable:** One of Primary's proven unicorn exits. Nearly 600 banks/fintechs/credit unions as clients

---

## Investment Patterns & Themes

### ðŸŽ¯ **Core Thesis: Vertical AI Dominance**
Primary is betting heavily on **AI applied to specific workflows**, not horizontal infrastructure:
- **Healthcare AI:** Valerie Health, Inspiren, Dandelion Health, K Health (earlier)
- **Financial services AI:** Tabs, Maybern, Alloy
- **Sales/GTM AI:** 1mind (most aggressive agent play)
- **Construction AI:** Bobyard (computer vision for vertical)

### ðŸ’¡ **Stage Preference: Seed â†’ Series A**
- Consistently leads or co-leads seed rounds
- Often follows-on in Series A (Inspiren, Etched, Maybern, Tabs)
- Fund V ($625M) maintains seed focus despite size

### ðŸš€ **Frontier Technology Bets**
Primary takes contrarian positions on **compute infrastructure**:
- **Biological Computing Company** - living neurons (most radical)
- **Etched** - ASICs for transformers
- Both challenge assumptions about compute efficiency and future AI infrastructure

### ðŸ¤– **Agent-First Thesis**
Clear pattern toward **AI agents that replace or augment workers**:
- **1mind** - explicitly replaces GTM employees
- **Tabs** - AI agents in finance operations
- **Bobyard** - replaces estimator hours
- **Valerie Health** - automates healthcare tasks
- **Inspiren** - AI monitoring/decision-making

### ðŸ—ï¸ **B2B SaaS, Not Consumer**
Almost entirely focused on:
- Enterprise software
- Fintech/financial infrastructure  
- Healthcare technology
- Vertical SaaS with AI

**Exception:** Chief (women's executive network) - but even that serves business leaders

### ðŸŒ† **NYC Connection Weakening**
Originally "NYC's leading early stage firm," but recent investments show:
- **San Francisco:** The Biological Computing Company
- **California:** Bobyard (Menlo Park), Valerie Health (Lafayette)
- Fund V explicitly "nationwide" focus

### ðŸ’° **Portfolio Impact Model**
Distinctive approach:
- Portfolio Impact team **outnumbers investors**
- Spend millions annually on value-add services
- Focus on helping companies "from seed to Series A"
- Track record: 2x Series A success rate, 19x unicorn rate

---

## What Primary DOESN'T Bet On

- âŒ Consumer apps/marketplaces (moved away from this)
- âŒ Web3/crypto (no evidence)
- âŒ Deep hardware (except AI-specific: Etched, TBC)
- âŒ Life sciences/biotech proper (prefer health tech/AI)
- âŒ Climate (occasional like Dandelion Energy, but not core)

---

## Key Insights for Applications

### 1. **Contrarian Compute Thesis**
Primary wrote the thesis ["Our Compute Thesis: Etched and Beyond"](https://www.primary.vc/articles/our-compute-thesis-etched-and-beyond) - they believe:
- Radical breakthroughs in compute needed for AI efficiency
- Outlier founders with unique perspectives will build the future
- Willing to back "stuff of sci-fi but very real" (TBC quote)

### 2. **Founder Profile They Love**
From TBC investment thesis:
> "Brilliant, on a mission, and wildly different"
- Deep domain expertise (neurosurgeons, ex-operators)
- Non-obvious backgrounds solving hard problems
- Long-term partnerships (TBC founders: 20-year collaboration)

### 3. **Vertical AI > Horizontal AI**
They're not investing in:
- General-purpose LLM wrappers
- Horizontal AI tools
Instead: **AI that deeply understands a workflow** (construction estimating, fund accounting, senior care)

### 4. **Market Timing Philosophy**
> "We back founders building things the world hasn't seen yet, **at the moment before the world believes**"

This explains TBC (biological computing), Etched (ASIC gamble), 1mind (AI replacing employees)

### 5. **2026 Investment Thesis Areas** (from website)
- **GTM Tech** (Cassie Young leading - see 1mind investment)
- **AI infrastructure/compute** (Brad Svrluga - see Etched, TBC)
- **Healthcare** (Sam Toole - see Valerie, Inspiren)

---

## Competitive Landscape

**Seed peers with similar AI focus:**
- Conviction (AI agents, automation)
- Chapter One (vertical AI)
- Work-Bench (enterprise AI, NYC-focused)

**What differentiates Primary:**
- Largest Portfolio Impact team at seed
- Higher follow-on rates (supports through Series A+)
- Contrarian infrastructure bets (not just application layer)
- Track record: 1/3 of Fund I = unicorns

---

## Sources & Confidence

**High confidence (verified from multiple sources):**
- TBC, Etched, 1mind, Tabs, Inspiren, Bobyard, Valerie Health investment details
- Fund V size ($625M)
- Track record statistics (2x Series A rate, 19x unicorn rate)

**Medium confidence (single source or timing unclear):**
- Exact investment dates for Maybern, Dandelion
- Earlier investments like Alloy, Chief (confirmed portfolio, timing fuzzy)

**Research Methodology:**
- Web search across Crunchbase, PitchBook, Primary's website, press releases
- Cross-referenced company announcements with Primary portfolio claims
- Prioritized most recent investments (2024-2026)

---

**End of Report**

*This research focuses on identifying patterns in Primary's recent investment behavior to inform application strategy. All data sourced from public announcements, press releases, and VC databases as of Feb 2026.*
